CORRECTION FROM SOURCE: Hemogenyx Pharmaceuticals PLC Announces Issue of Equity

The following amendment has been made to the Issue of Equity' announcement released on 10 February 2026.The sentence "through a direct subscription for 313,333 new ordinary shares in the Company at a price of £7.50 per share" has been …